Pharmaceutical Companies Drive Commercial Demand and Clinical...

hat ein neuen Blog hinzugefügt Health

2026-07-30 05:24:07 -

Pharmaceutical Companies Drive Commercial Demand and Clinical Validation

The end-use segmentation of the US 3D Bioprinting Market reveals pharmaceutical companies as the dominant stakeholders, commanding the highest valuation at $321.36 million in 2024. This dominance reflects the pharmaceutical industry's urgent need for more predictive preclinical testing platforms and the substantial research and development budgets these organizations can allocate toward...

0 Kommentare 0 Geteilt 3 Ansichten 0 Bewertungen